{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:03:59Z","timestamp":1791198239341,"version":"4.1.0"},"reference-count":31,"publisher":"BMJ","issue":"6983","license":[{"start":{"date-parts":[[1995,4,1]],"date-time":"1995-04-01T00:00:00Z","timestamp":796694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"accepted":{"date-parts":[[1995,1,31]]},"published-print":{"date-parts":[[1995,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective<\/jats:bold>\n                    : To determine the risks of hospitalisation for bleeding peptic ulcer with the current prophylactic aspirin regimens of 300 mg daily or less.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Design<\/jats:bold>\n                    : A case-control study with hospital and community controls.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Setting<\/jats:bold>\n                    : Hospitals in Glasgow, Newcastle, Nottingham, Oxford, and Portsmouth.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Subjects<\/jats:bold>\n                    : 1121 patients with gastric or duodenal ulcer bleeding matched with hospital and community controls.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    : 144 (12.8%) cases had been regular users of aspirin (taken at least five days a week for at least the previous month) compared with 101 (9.0%) hospital and 77 (7.8%) community controls. Odds ratios were raised for all doses of aspirin taken, whether compared with hospital or community controls (compared with combined controls: 75 mg, 2.3 (95% confidence interval 1.2 to 4.4); 150 mg, 3.2 (1.7 to 6.5); 300 mg, 3.9 (2.5 to 6.3)). Results were not explained by confounding influences of age, sex, prior ulcer history or dyspepsia, or concurrent non-aspirin non-steroidal anti-inflammatory drug use. Risks seemed particularly high in patients who took non-aspirin non-steroidal anti-inflammatory drugs concurrently.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion<\/jats:bold>\n                    : No conventionally used prophylactic aspirin regimen seems free of the risk of peptic ulcer complications.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:boxed-text position=\"float\">\n                      <jats:sec>\n                        <jats:title>Key messages<\/jats:title>\n                        <jats:list list-type=\"bullet\">\n                          <jats:list-item>\n                            <jats:p>Key messages<\/jats:p>\n                          <\/jats:list-item>\n                          <jats:list-item>\n                            <jats:p>This finding applies to doses in common use of 75, 150, and 300 mg daily<\/jats:p>\n                          <\/jats:list-item>\n                          <jats:list-item>\n                            <jats:p>Despite these results, overall benefits of treatment are likely considerably to outweigh possible risks<\/jats:p>\n                          <\/jats:list-item>\n                        <\/jats:list>\n                      <\/jats:sec>\n                    <\/jats:boxed-text>\n                  <\/jats:p>","DOI":"10.1136\/bmj.310.6983.827","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T19:33:49Z","timestamp":1319744029000},"page":"827-830","source":"Crossref","is-referenced-by-count":423,"title":["Prophylactic aspirin and risk of peptic ulcer bleeding"],"prefix":"10.1136","volume":"310","author":[{"given":"John","family":"Weil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Colin-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Langman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rawlins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Vessey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Wainwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1995,4,1]]},"reference":[{"key":"2025122509494405000_310.6983.827.1","first-page":"179","article-title":"Gastrointestinal haemorrhage and salicylates.","volume":"ii","author":"Alvarez","year":"1958","journal-title":"Lancet"},{"key":"2025122509494405000_310.6983.827.2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.23.4.340"},{"key":"2025122509494405000_310.6983.827.3","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1988.00380020025005"},{"key":"2025122509494405000_310.6983.827.4","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/bmj.297.6659.1311","article-title":"Aspirin and bleeding peptic ulcers in the elderly.","volume":"297","author":"Faulkner","year":"1988","journal-title":"BMJ"},{"key":"2025122509494405000_310.6983.827.5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(86)92927-2","article-title":"Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer.","volume":"i","author":"Somerville","year":"1986","journal-title":"Lancet"},{"key":"2025122509494405000_310.6983.827.6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-114-4-257","article-title":"Non-steroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons.","volume":"114","author":"Griffin","year":"1991","journal-title":"Ann Intern Med"},{"key":"2025122509494405000_310.6983.827.7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0140-6736(91)90744-A","article-title":"Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs.","volume":"336","author":"Laporte","year":"1991","journal-title":"Lancet"},{"key":"2025122509494405000_310.6983.827.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90185-6"},{"key":"2025122509494405000_310.6983.827.9","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.14.1.5"},{"key":"2025122509494405000_310.6983.827.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197807132990201"},{"key":"2025122509494405000_310.6983.827.11","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.14.1.15"},{"key":"2025122509494405000_310.6983.827.12","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(79)92808-3","article-title":"Aspirin and secondary mortality after myocardial infarction.","volume":"ii","author":"Elwood","year":"1979","journal-title":"Lancet"},{"key":"2025122509494405000_310.6983.827.13","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.62.3.449"},{"issue":"suppl V","key":"2025122509494405000_310.6983.827.14","first-page":"79","article-title":"The aspirin myocardial infarction study: final results.","volume":"62","year":"1980","journal-title":"Circulation"},{"key":"2025122509494405000_310.6983.827.15","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(76)90020-5"},{"key":"2025122509494405000_310.6983.827.16","first-page":"325","article-title":"Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon.","volume":"19","author":"Breddin","year":"1980","journal-title":"Haemostasis"},{"key":"2025122509494405000_310.6983.827.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198511283132201"},{"key":"2025122509494405000_310.6983.827.18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/bmj.296.6618.316","article-title":"United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results.","volume":"296","year":"1988","journal-title":"BMJ"},{"key":"2025122509494405000_310.6983.827.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198907203210301"},{"key":"2025122509494405000_310.6983.827.20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bmj.1.5905.436","article-title":"A randomised controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction.","volume":"i","author":"Elwood","year":"1974","journal-title":"BMJ"},{"key":"2025122509494405000_310.6983.827.21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/bmj.298.6672.493","article-title":"Human gastric mucosal bleeding induced by low dose aspirin but not warfarin.","volume":"298","author":"Pritchard","year":"1989","journal-title":"BMJ"},{"key":"2025122509494405000_310.6983.827.22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebocontrolled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation.","volume":"i","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"2025122509494405000_310.6983.827.23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1656307","article-title":"Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation.","volume":"68","author":"Meade","year":"1992","journal-title":"Thromb Haemost"},{"key":"2025122509494405000_310.6983.827.24","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(91)92233-R","article-title":"Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events.","volume":"338","year":"1991","journal-title":"Lancet"},{"key":"2025122509494405000_310.6983.827.25","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92233-R"},{"key":"2025122509494405000_310.6983.827.26","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92336-G"},{"key":"2025122509494405000_310.6983.827.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199110313251801"},{"key":"2025122509494405000_310.6983.827.28","first-page":"A165","article-title":"Risks of upper GI bleeding during TIA prophylaxis with aspirin.","volume":"102","author":"Shorrock","year":"1992","journal-title":"Gastroenterology"},{"key":"2025122509494405000_310.6983.827.29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/bmj.290.6465.347","article-title":"Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage.","volume":"290","author":"Langman","year":"1985","journal-title":"BMJ"},{"key":"2025122509494405000_310.6983.827.30","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/0016-5085(88)90568-9","article-title":"Clinicopathological features of non-steroidal anti-inflammatory druginduced small intestinal strictures.","volume":"94","author":"Bjarnason","year":"1988","journal-title":"Gastroenterology"},{"key":"2025122509494405000_310.6983.827.31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0016-5085(87)90909-7","article-title":"Non-steroidal anti-inflammatory drug induced intestinal inflammation in humans.","volume":"93","author":"Bjarnason","year":"1987","journal-title":"Gastroenterology"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.310.6983.827","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.310.6983.827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T17:49:57Z","timestamp":1766684997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.310.6983.827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4,1]]},"references-count":31,"journal-issue":{"issue":"6983","published-online":{"date-parts":[[1995,4,1]]},"published-print":{"date-parts":[[1995,4,1]]}},"alternative-id":["10.1136\/bmj.310.6983.827"],"URL":"https:\/\/doi.org\/10.1136\/bmj.310.6983.827","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,4,1]]}}}